Free Trial

Anpario (LON:ANP) Stock Crosses Below 200-Day Moving Average - Here's What Happened

Anpario logo with Consumer Defensive background

Anpario plc (LON:ANP - Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 415.01 ($5.58) and traded as low as GBX 395 ($5.31). Anpario shares last traded at GBX 410 ($5.51), with a volume of 96,774 shares.

Analyst Upgrades and Downgrades

Separately, Shore Capital reissued a "house stock" rating on shares of Anpario in a research note on Monday, March 31st.

Get Our Latest Analysis on ANP

Anpario Stock Performance

The company's fifty day moving average price is GBX 426.13 and its 200 day moving average price is GBX 415.01. The company has a market cap of £69.95 million, a PE ratio of 22.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16.

Anpario (LON:ANP - Get Free Report) last announced its earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.38) EPS for the quarter. Anpario had a net margin of 9.23% and a return on equity of 8.74%. On average, equities research analysts predict that Anpario plc will post 23.5757801 earnings per share for the current year.

Anpario Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, July 25th. Shareholders of record on Thursday, July 10th will be given a GBX 8 ($0.11) dividend. This is a positive change from Anpario's previous dividend of $3.25. The ex-dividend date is Thursday, July 10th. This represents a yield of 2.09%. Anpario's payout ratio is currently 60.74%.

Insiders Place Their Bets

In other Anpario news, insider Marc Wilson bought 3,778 shares of Anpario stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average price of GBX 398 ($5.35) per share, for a total transaction of £15,036.44 ($20,221.14). Insiders own 30.51% of the company's stock.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines